The Skeletal Effects of Inhaled Glucocorticoids

Overview

Journal Curr Osteoporos Rep

Publisher Current Science

Specialties Endocrinology
Orthopedics

Date 2016 Apr 20

PMID 27091558

Citations 14

Authors

Stephanie A Sutter

Emily M Stein

Affiliations

Soon will be listed here.

Abstract

The skeletal effects of inhaled glucocorticoids are poorly understood. Children with asthma treated with inhaled glucocorticoids have lower growth velocity, bone density, and adult height. Studies of adults with asthma have reported variable effects on BMD, although prospective studies have demonstrated bone loss after initiation of inhaled glucocorticoids in premenopausal women. There is a dose-response relationship between inhaled glucocorticoids and fracture risk in asthmatics; the risk of vertebral and non-vertebral fractures is greater in subjects treated with the highest doses in the majority of studies. Patients with COPD have lower BMD and higher fracture rates compared to controls, however, the majority of studies have not found an additional detrimental effect of inhaled glucocorticoids on bone. While the evidence is not conclusive, it supports using the lowest possible dose of inhaled glucocorticoids to treat patients with asthma and COPD and highlights the need for further research on this topic.

Citing Articles

Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?.

Pofi R, Caratti G, Ray D, Tomlinson J Endocr Rev. 2023; 44(6):975-1011.

PMID: 37253115 PMC: 10638606. DOI: 10.1210/endrev/bnad016.

Clinical assessment of balance and functional impairments in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Nunez-Cortes R, Padilla-Acevedo P, Vergara-Pena F, Molla-Casanova S, Espinoza-Bravo C, Torres-Castro R ERJ Open Res. 2023; 8(4).

PMID: 36655220 PMC: 9835973. DOI: 10.1183/23120541.00164-2022.

Clinical Effects of Rehabilitation on Balance in People With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

Canales-Diaz M, Olivares-Valenzuela C, Ramirez-Arriagada A, Cruz-Montecinos C, Vilaro J, Torres-Castro R Front Med (Lausanne). 2022; 9:868316.

PMID: 35602508 PMC: 9120665. DOI: 10.3389/fmed.2022.868316.

Secondary Osteoporosis and Metabolic Bone Diseases.

Sobh M, Abdalbary M, Elnagar S, Nagy E, Elshabrawy N, Abdelsalam M J Clin Med. 2022; 11(9).

PMID: 35566509 PMC: 9102221. DOI: 10.3390/jcm11092382.

Abnormal Bone Tissue Organization and Osteocyte Lacunocanalicular Network in Early-Onset Osteoporosis Due to Mutations.

Makitie R, Blouin S, Valimaki V, Pihlstrom S, Maatta K, Pekkinen M JBMR Plus. 2021; 5(11):e10537.

PMID: 34761145 PMC: 8567487. DOI: 10.1002/jbm4.10537.

References

Sutter S, Nishiyama K, Kepley A, Zhou B, Wang J, McMahon D . Abnormalities in cortical bone, trabecular plates, and stiffness in postmenopausal women treated with glucocorticoids. J Clin Endocrinol Metab. 2014; 99(11):4231-40. PMC: 4223438. DOI: 10.1210/jc.2014-2177. View

Richy F, Bousquet J, Ehrlich G, Meunier P, Israel E, Morii H . Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int. 2003; 14(3):179-90. DOI: 10.1007/s00198-003-1398-z. View

Dam T, Harrison S, Fink H, Ramsdell J, Barrett-Connor E . Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporos Int. 2009; 21(8):1341-9. PMC: 2895883. DOI: 10.1007/s00198-009-1076-x. View

van Staa T, Laan R, Barton I, Cohen S, Reid D, Cooper C . Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. 2003; 48(11):3224-9. DOI: 10.1002/art.11283. View

Hodsman A, Toogood J, Jennings B, Fraher L, Baskerville J . Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab. 1991; 72(3):530-40. DOI: 10.1210/jcem-72-3-530. View

Jemal A, Ward E, Hao Y, Thun M . Trends in the leading causes of death in the United States, 1970-2002. JAMA. 2005; 294(10):1255-9. DOI: 10.1001/jama.294.10.1255. View

Israel E, Banerjee T, Fitzmaurice G, Kotlov T, LaHive K, LeBoff M . Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001; 345(13):941-7. DOI: 10.1056/NEJMoa002304. View

Elmstahl S, Ekstrom H, Galvard H, Johnell O, Gerhardsson de Verdier M, Norjavaara E . Is there an association between inhaled corticosteroids and bone density in postmenopausal women?. J Allergy Clin Immunol. 2003; 111(1):91-6. DOI: 10.1067/mai.2003.4. View

Moorman J, Anne Rudd R, Johnson C, King M, Minor P, Bailey C . National surveillance for asthma--United States, 1980-2004. MMWR Surveill Summ. 2007; 56(8):1-54. View

10.

Lehouck A, Boonen S, Decramer M, Janssens W . COPD, bone metabolism, and osteoporosis. Chest. 2011; 139(3):648-657. DOI: 10.1378/chest.10-1427. View

11.

van Staa T, Leufkens H, Abenhaim L, Zhang B, Cooper C . Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford). 2001; 39(12):1383-9. DOI: 10.1093/rheumatology/39.12.1383. View

12.

Tantucci C . COPD and osteoporosis: something more than a comorbidity. Endocrine. 2012; 42(1):5-6. DOI: 10.1007/s12020-012-9686-z. View

13.

Jung J, Kang H, Kim J, Lee S, Kim S, Cho S . Are asthmatic patients prone to bone loss?. Ann Allergy Asthma Immunol. 2014; 112(5):426-31. DOI: 10.1016/j.anai.2014.02.013. View

14.

Hubbard R, Smith C, Smeeth L, Harrison T, Tattersfield A . Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med. 2002; 166(12 Pt 1):1563-6. DOI: 10.1164/rccm.200206-606OC. View

15.

van Staa T, Leufkens H, Cooper C . The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002; 13(10):777-87. DOI: 10.1007/s001980200108. View

16.

Hughes J, Conry B, Male S, Eastell R . One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density. Thorax. 1999; 54(3):223-9. PMC: 1745450. DOI: 10.1136/thx.54.3.223. View

17.

Misof B, Roschger P, Jorgetti V, Klaushofer K, Borba V, Boguszewski C . Subtle changes in bone mineralization density distribution in most severely affected patients with chronic obstructive pulmonary disease. Bone. 2015; 79:1-7. DOI: 10.1016/j.bone.2015.05.018. View

18.

Loke Y, Cavallazzi R, Singh S . Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax. 2011; 66(8):699-708. DOI: 10.1136/thx.2011.160028. View

19.

Ali N, Capewell S, Ward M . Bone turnover during high dose inhaled corticosteroid treatment. Thorax. 1991; 46(3):160-4. PMC: 463016. DOI: 10.1136/thx.46.3.160. View

20.

Scanlon P, Connett J, Wise R, Tashkin D, Madhok T, Skeans M . Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med. 2004; 170(12):1302-9. DOI: 10.1164/rccm.200310-1349OC. View